Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins

Steroids

Volumn 78, Issue 2, 2013, Pages 255-267

  Nickisch, Klaus ^a   Elger, Walter ^a   Cessac, James ^a   Kesavaram, Narkunan ^a   Das, Baishakhi ^a   Garfield, Robert ^b   Shi, Shao Qing ^b   Amelkina, Olga ^c   Meister, Reinhard ^d  

^a EVESTRA INC   (United States)

^b ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^c LEIBNIZ INSTITUTE FOR ZOO AND WILDLIFE RESEARCH   (Germany)

^d Beuth Hochschule   (Germany)

Author keywords

Antiproliferation; Fluorine; Mesoprogestins

Indexed keywords

ANTIGESTAGEN; FLUORINE; GESTAGEN; GLUCOCORTICOID ANTAGONIST; MESOPROGESTIN; MIFEPRISTONE; SEX HORMONE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENDOMETRIOSIS; FEMALE; FLUORINATION; IN VITRO STUDY; IN VIVO STUDY; METRORRHAGIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; UTERUS MYOMA;

ANIMALS; FEMALE; GUINEA PIGS; HALOGENATION; HEK293 CELLS; HORMONE ANTAGONISTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIFEPRISTONE; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; VAGINA;

EID: 84871556955     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.09.010     Document Type: Article

References (27)

1. L. Klein Hitpass, A.C. Cato, D. Henderson, and G.U. Ryffel Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells Nucleic Acids Res 19 1991 1227 1234
2. A. Belanger, D. Philibert, and G. Teutsch Regio and steriospecific synthesis of 11β-substituted 19-norsteroids Steroids 37 1981 361 382
3. W. Elger, J. Bartley, B. Schneider, G. Kaufmann, G. Schubert, and K. Chwalisz Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity Steroids 65 2000 713 723
4. K. Chwalisz, M.C. Perez, D. Demanno, C. Winkel, G. Schubert, and W. Elger Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis Endocr Rev 26 2005 423 438
5. G. Teutsch, and D. Philibert History and perspectives of antiprogestins from the chemist's point of view Hum Reprod 9 Suppl. 1 1994 12 31
6. W.G.E.H. Schoonen, G.J. Vermeulen, G.H. Deckers, P.M. Verbost, and H.J. Klooserboer Antiprogestins: their mechanism of action and the consequences for compound selection by in vitro and in vivo studies Curr Top Steroid Res 2 1999 15 54
7. G. Neef, S. Beier, W. Elger, D. Henderson, and R. Wiechert New steroids with antiprogestational and antiglucocorticoid activities Steroids 44 1984 349 372
8. C. Jin, G. Manikumar, J.A. Kepler, C.E. Cook, G.F. Allan, and M. Kiddoe Synthesis and identification of novel 11β-aryl-4′,5′- dihydrospiro[estra-4,9-diene-17β,4′-oxazole] analogs with dissociative antiprogesterone activities Bioorg Med Chem Lett 17 2007 5754 5757
9. B.J. Attardi, J. Burgenson, S.A. Hild, and J. Reel In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone J Steroid Biochem Mol Biol 88 2004 277 288
10. H.J. Kloosterboer, G.H. Deckers, W.G.E.J. Schoonen, R.G.J.M. Hanssen, U.M. Rose, and P.M. Verbost Preclinical experience with two selective progesterone receptor modulators on breast and endometrium Steroids 65 2000 733 740
11. A. Cleve, U. Klar, and W. Schwede Beneficial effects of fluorine in the anti-progestin ZK 230211 J Fluorine Chem 126 2005 217 220
12. K.P. Madauss, E.T. Grygielko, S.-J. Deng, A.C. Sulpizio, T.B. Stanley, and C. Wu A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator Mol Endocrinol 21 2007 1066 1081
13. J. Rewinkel, M. Enthoven, I. Golstein, M. van der Rijst, A. Scholten, and M. van Tilborg 11-(Pyridinylphenyl)steroids-a new class of mixed-profile progesterone agonists/antagonists Bioorg Med Chem 16 2008 2753 2763
14. H. Raaijmakers, J.E. Versteegh, and C. Uitdehaag The X-ray structure of RU486 bound to the progesterone receptor in a destabilized afonistic conformation J Biol Chem 284 2009 19572 19579
15. V.C. Jordan Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions J Med Chem 46 2003 883 908
16. D.P. McDonnell The molecular pharmacology of SERMs Trends Endocrinol Metab 10 1999 301 311
17. Chwalisz K, Williams A, Brenner R. Endometrial effects of selective progesterone receptor modulators. In: Aplin J, Fazleabas A, Glasser S, Guidice L, editors. The endometrium: molecular cellular and clinical perspectives; Taylor & Francis, 2008. p. 613-622 [chapter 39].
18. W. Elger, G. Schubert, B. Kosub, S. Matz, B. Schneider, and K. Chwalisz The effects of the novel selective progesterone receptor modulator (SPRM) asoprisnil on the morphology of the reproductive tract of cycling and ovariectomized guinea pigs Fertil Steril 82 2004 315 [Abstract P-507]
19. W. Elger, G. Neef, S. Beier, M. Fähnrich, M. Gründel, and J. Heermann Evaluation of antifertility activities of antigestagens in animal models C.P. Puri, P.F.A. Van Look, Current concepts in fertility regulation and reproduction 1992 Wiley Eastern limited, New Age International Limited New Delhi 303 328
20. K. Chwalisz, W. Elger, K. McCrary, P. Beckman, and L. Larsen Reversible suppression of menstruation in normal women irrespective of the effect on ovulation with the novel selective progesterone receptor modulator (SPRM) J867 J Soc Gynecol Invest 9 Suppl. 1 2002 [Abstract 49]
21. P.N. Rao, Z. Wang, J.W. Cessac, R.S. Rosenberg, D.J.A. Jenkins, and E.P. Diamandis New 11β-aryl-substituted steroids exhibit both progestational and antiprogestational activity Steroids 63 1998 523 530
22. Kim HK, Blye RP, Rao PN, Cessac JW, Acosta CK, Simmons AM. Structural modification of 19-norprogesterone I: 17-α-substituted-11-β- substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents. US Patent Number 6,900,193; 2005.
23. A. Liu, K.E. Carlson, and J.A. Katzenellenbogen Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography J Med Chem 35 1992 2113 2129
24. W. Jiang, G. Allan, J.J. Fiordeliso, O. Linton, P. Tannenbaum, and J. Xu New progesterone receptor antagonists: phosphorus-containing 11β-aryl-substituted steroids Bioorg Med Chem 14 2006 6726 6732
25. W. Elger, M. Fahnrich, S. Beier, S.S. Qing, and K. Chwalisz Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs Am J Obstet Gynecol 157 1987 1065 1074
26. S. Holm A simple sequentially rejective multiple test procedure Scand J Statist 6 1979 65 70
27. I.M. Spitz Clinical utility of progesterone receptor modulators and their effect on the endometrium Curr Opin Obstet Gynecol 21 2009 318 324